Cross-Linked Polyelectrolyte (CLP)
DrugCLP was administered orally, in capsules, for 7 consecutive days.
NCT Number: NCT02079233
This is a study to determine the effect of four different dosing regimens of CLP in normal healthy volunteers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CLP was administered orally, in capsules, for 7 consecutive days.
Time frame: Baseline (Days 3-6) vs. Treatment (Days 10-13)
The primary endpoint was sodium removal from the stool compared between the Baseline period and the Treatment Period.
Sorbent Therapeutics
Industry
Phase 1 Multiple Dose Trial to Assess the Safety, Tolerability and Efficacy of Four Different Dosing Regimens of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details